Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting

Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting

Purpose: This study aimed to evaluate the clinical efficacy of enzalutamide in chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) patients using real-world data from Korean patients. Materials and Methods: We retrospectively reviewed the medical records of 199 chemotherapy-na...

Full description

Bibliographic Details
Main Authors: Seung Il Jung, Myung Soo Kim, Chang Wook Jeong, Cheol Kwak, Sung Kyu Hong, Seok Ho Kang, Jae Young Joung, Seung Hwan Lee, Seok Joong Yun, Tae-Hwan Kim, Sung Woo Park, Seong Soo Jeon, Minyong Kang, Ji Youl Lee, Byung Ha Chung, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim, Dong Deuk Kwon
Format: Article
Language:English
Published: Korean Urological Association 2020-01-01
Series:Investigative and Clinical Urology
Subjects:
androgen antagonists
neoplasm metastasis
prostate neoplasms
treatment outcome
Online Access:https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-61-19.pdf

Internet

https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-61-19.pdf

Similar Items